<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evaluation and management of elevated intracranial pressure in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evaluation and management of elevated intracranial pressure in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Evaluation and management of elevated intracranial pressure in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward R Smith, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sepideh Amin-Hanjani, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael J Aminoff, MD, DSc</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 26, 2019.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Elevated intracranial pressure (ICP) is a potentially devastating complication of neurologic injury. Elevated ICP may complicate trauma, central nervous system (CNS) tumors, hydrocephalus, hepatic encephalopathy, and impaired CNS venous outflow (<a class="graphic graphic_table graphicRef69683" href="/d/graphic/69683.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. Successful management of patients with elevated ICP requires prompt recognition, the judicious use of invasive monitoring, and therapy directed at both reducing ICP and reversing its underlying cause.</p><p>The evaluation and management of adult patients with elevated ICP will be reviewed here. Elevated ICP in children and specific causes and complications of elevated ICP (eg, ischemic stroke, intracerebral hemorrhage, traumatic brain injury) are discussed separately. (See  <a class="medical medical_review" href="/d/html/6077.html" rel="external">"Elevated intracranial pressure (ICP) in children: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Intracranial pressure management'</a> and  <a class="medical medical_review" href="/d/html/1126.html" rel="external">"Initial assessment and management of acute stroke"</a> and  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis", section on 'Early complications'</a> and  <a class="medical medical_review" href="/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Intracranial pressure management'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PHYSIOLOGY</span><span class="headingEndMark"> — </span>ICP is normally ≤15 mmHg in adults, and pathologic intracranial hypertension (ICH) is present at pressures ≥20 mmHg. ICP is normally lower in children than adults, and may be subatmospheric in newborns [<a href="#rid2">2</a>]. Homeostatic mechanisms stabilize ICP, with occasional transient elevations associated with physiologic events, including sneezing, coughing, or Valsalva maneuvers.</p><p class="headingAnchor" id="H3"><span class="h2">Intracranial components</span><span class="headingEndMark"> — </span>In adults, the intracranial compartment is protected by the skull, a rigid structure with a fixed internal volume of 1400 to 1700 mL. Under physiologic conditions, the intracranial contents include (by volume) [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Brain parenchyma – 80 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebrospinal fluid (CSF) – 10 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Blood – 10 percent</p><p></p><p>Pathologic structures, including mass lesions, abscesses, and hematomas, also may be present within the intracranial compartment. Since the overall volume of the cranial vault cannot change, an increase in the volume of one component, or the presence of pathologic components, necessitates the displacement of other structures, an increase in ICP, or both. Thus, ICP is a function of the volume and compliance of each component of the intracranial compartment, an interrelationship known as the Monro-Kellie doctrine [<a href="#rid4">4,5</a>].</p><p>The volume of brain parenchyma is relatively constant in adults, although it can be altered by mass lesions or in the setting of cerebral edema (<a class="graphic graphic_figure graphicRef65853" href="/d/graphic/65853.html" rel="external">figure 1</a>). The volumes of CSF and blood in the intracranial space vary to a greater degree. Abnormal increases in the volume of any component may lead to elevations in ICP.</p><p>CSF is produced by the choroid plexus and elsewhere in the central nervous system (CNS) at a rate of approximately 20 mL/hour (500 mL/day) [<a href="#rid6">6</a>]. CSF is normally resorbed via the arachnoid granulations into the venous system. Problems with CSF regulation generally result from impaired outflow caused by ventricular obstruction or venous congestion; the latter can occur in patients with sagittal (or other) venous sinus thrombosis. Much less frequently, CSF production can become pathologically increased; this may be seen in the setting of choroid plexus papilloma. (See  <a class="medical medical_review" href="/d/html/1285.html" rel="external">"Cerebrospinal fluid: Physiology and utility of an examination in disease states"</a>.)</p><p>Cerebral blood flow (CBF) determines the volume of blood in the intracranial space. CBF increases with hypercapnia and hypoxia. Other determinants of CBF are discussed below. Autoregulation of CBF may be impaired in the setting of neurologic injury, and may result in rapid and severe brain swelling, especially in children [<a href="#rid7">7-9</a>].</p><p>In summary, the major causes of increased ICP include:</p><p class="bulletIndent1"><span class="glyph">●</span>Intracranial mass lesions (eg, tumor, hematoma)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cerebral edema (such as in acute hypoxic-ischemic encephalopathy, large cerebral infarction, severe traumatic brain injury)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased CSF production (eg, choroid plexus papilloma)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Decreased CSF absorption (eg, arachnoid granulation adhesions after bacterial meningitis)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obstructive hydrocephalus</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obstruction of venous outflow (eg, venous sinus thrombosis, jugular vein compression, neck surgery)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic ICH (pseudotumor cerebri)</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Intracranial compliance</span><span class="headingEndMark"> — </span>The interrelationship between changes in the volume of intracranial contents and changes in ICP defines the compliance characteristics of the intracranial compartment. Intracranial compliance can be modeled mathematically (as in other physiologic and mechanical systems) as the change in volume over the change in pressure (dV/dP).</p><p>The compliance relationship is nonlinear, and compliance decreases as the combined volume of the intracranial contents increases. Initially, compensatory mechanisms allow volume to increase with minimal elevation in ICP. These mechanisms include:</p><p class="bulletIndent1"><span class="glyph">●</span>Displacement of CSF into the thecal sac</p><p class="bulletIndent1"><span class="glyph">●</span>Decrease in the volume of the cerebral venous blood via venoconstriction and extracranial drainage</p><p></p><p>However, when these compensatory mechanisms have been exhausted, significant increases in pressure develop with small increases in volume, leading to abnormally elevated ICP (<a class="graphic graphic_figure graphicRef54602" href="/d/graphic/54602.html" rel="external">figure 2</a>).</p><p>Thus, the magnitude of the change in volume of an individual structure determines its effect on ICP. In addition, the rate of change in the volume of the intracranial contents influences ICP. Changes that occur slowly produce less of an effect than those that are rapid. This can be recognized clinically in some patients who present with large meningiomas and minimally elevated or normal ICP. Conversely, other patients may experience symptomatic elevations in ICP from small hematomas that develop acutely.</p><p class="headingAnchor" id="H5"><span class="h2">Cerebral blood flow</span><span class="headingEndMark"> — </span>Following a significant increase in ICP, brain injury can result from brainstem compression and/or a reduction in CBF. CBF is a function of the pressure drop across the cerebral circulation divided by the cerebrovascular resistance, as predicted by Ohm's law [<a href="#rid10">10</a>]:</p><div class="formulaContainer"><div class="formula"><p>  CBF = (CAP - JVP) ÷ CVR</p></div></div><p>where CAP is carotid arterial pressure, JVP is jugular venous pressure, and CVR is cerebrovascular resistance.</p><p>Cerebral perfusion pressure (CPP) is a clinical surrogate for the adequacy of cerebral perfusion. CPP is defined as mean arterial pressure (MAP) minus ICP.</p><div class="formulaContainer"><div class="formula"><p>  CPP = MAP - ICP</p></div></div><p class="headingAnchor" id="H6"><span class="h3">Autoregulation</span><span class="headingEndMark"> — </span>CBF is normally maintained at a relatively constant level by cerebrovascular autoregulation of CVR over a wide range of CPP (50 to 100 mmHg) (<a class="graphic graphic_figure graphicRef57676" href="/d/graphic/57676.html" rel="external">figure 3</a>) [<a href="#rid11">11,12</a>]. However, autoregulation of CVR can become dysfunctional in certain pathologic states, most notably stroke or trauma. In this setting, the brain becomes exquisitely sensitive to even minor changes in CPP [<a href="#rid11">11-13</a>].</p><p>Another important consideration is that the set-point of autoregulation is also changed in patients with chronic hypertension. With mild to moderate elevations in blood pressure (BP), the initial response is arterial and arteriolar vasoconstriction. This autoregulatory process both maintains tissue perfusion at a relatively constant level and prevents the increase in pressure from being transmitted to the smaller, more distal vessels [<a href="#rid11">11</a>]. As a result, acute reductions in BP, even if the final value remains within the normal range, can produce ischemic symptoms in patients with chronic hypertension (<a class="graphic graphic_figure graphicRef57676" href="/d/graphic/57676.html" rel="external">figure 3</a>) [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H7"><span class="h3">Cerebral perfusion pressure</span><span class="headingEndMark"> — </span>Conditions associated with elevated ICP, including mass lesions and hydrocephalus, can be associated with a reduction in CPP. This can result in devastating focal or global ischemia. On the other hand, excessive elevation of CPP can lead to hypertensive encephalopathy and cerebral edema due to the eventual breakdown of autoregulation, particularly if the CPP is &gt;120 mmHg [<a href="#rid11">11,14,15</a>]. A higher level of CPP is tolerated in patients with chronic hypertension because the autoregulatory curve has shifted to the right (<a class="graphic graphic_figure graphicRef57676" href="/d/graphic/57676.html" rel="external">figure 3</a>) [<a href="#rid11">11,15</a>]. (See  <a class="medical medical_review" href="/d/html/3833.html" rel="external">"Moderate to severe hypertensive retinopathy and hypertensive encephalopathy in adults", section on 'Mechanisms of vascular injury'</a>.)</p><p>Ultimately, global or local reductions in CBF are responsible for the clinical manifestations of elevated ICP. These manifestations can be further divided into generalized responses to elevated ICP and herniation syndromes.</p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Global symptoms of elevated ICP include headache, which is probably mediated via the pain fibers of cranial nerve (CN) V in the dura and blood vessels, depressed global consciousness due to either the local effect of mass lesions or pressure on the midbrain reticular formation, and vomiting.</p><p>Signs include CN VI palsies, papilledema secondary to impaired axonal transport and congestion (<a class="graphic graphic_picture graphicRef50378" href="/d/graphic/50378.html" rel="external">picture 1</a>), spontaneous periorbital bruising [<a href="#rid16">16</a>], and a triad of bradycardia, respiratory depression, and hypertension (Cushing triad, sometimes called Cushing reflex or Cushing response) [<a href="#rid3">3</a>]. While the mechanism of Cushing triad remains controversial, many believe that it relates to brainstem compression. The presence of this response is an ominous finding that requires urgent intervention.</p><p>Focal symptoms of elevated ICP may be caused by local effects in patients with mass lesions or by herniation syndromes. Herniation results when pressure gradients develop between two regions of the cranial vault. The most common anatomic locations affected by herniation syndromes include subfalcine, central transtentorial, uncal transtentorial, upward cerebellar, cerebellar tonsillar/foramen magnum, and transcalvarial (<a class="graphic graphic_figure graphicRef76974" href="/d/graphic/76974.html" rel="external">figure 4</a>) [<a href="#rid3">3,17</a>]. (See  <a class="medical medical_review" href="/d/html/5104.html" rel="external">"Stupor and coma in adults", section on 'Neurologic examination'</a> and  <a class="medical medical_review" href="/d/html/5104.html" rel="external">"Stupor and coma in adults", section on 'Coma syndromes'</a>.)</p><p>One notable false localizing syndrome seen following neurologic injury, referred to as Kernohan's notch phenomenon, consists of the combination of contralateral pupillary dilatation and ipsilateral weakness [<a href="#rid18">18,19</a>]. Because the diagnostic accuracy of signs and symptoms is limited, the findings described above may be inconstant or unreliable in any given case. Use of radiologic studies may support the diagnosis; however, the most reliable method of diagnosing elevated ICP is to measure it directly.</p><p class="headingAnchor" id="H9"><span class="h1">ICP MONITORING</span><span class="headingEndMark"> — </span>Empiric therapy for presumed elevated ICP is unsatisfactory because cerebral perfusion pressure (CPP) cannot be monitored reliably without measurement of ICP. Furthermore, most therapies directed at lowering ICP are effective for limited and variable periods of time. In addition, these treatments may have serious side effects. Therefore, while initial steps to control ICP may, by necessity, be performed without the benefit of ICP monitoring, an important early goal in management of the patient with presumed elevated ICP is placement of an ICP monitoring device.</p><p>The purpose of monitoring ICP is to improve the clinician's ability to maintain adequate CPP and oxygenation. The only way to reliably determine CPP (defined as the difference between mean arterial pressure [MAP] and ICP) is to continuously monitor both ICP and blood pressure (BP). In general, these patients are managed in intensive care units (ICUs) with an ICP monitor and arterial line. The combination of ICP monitoring and concomitant management of CPP may improve patient outcomes, particularly in patients with closed head trauma [<a href="#rid20">20-23</a>]. The specific therapeutic targets for CPP in patients with traumatic brain injury are discussed separately. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Hemodynamic management'</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Indications</span><span class="headingEndMark"> — </span>The diagnosis of elevated ICP generally is based on clinical findings and corroborated by imaging studies and the patient's medical history. Closed head injury is one of the most frequent and best-studied indications for ICP monitoring. Much of the current practice of ICP monitoring has been derived from clinical experience with closed head trauma patients [<a href="#rid24">24</a>]. Indications for ICP monitoring in patients with traumatic brain injury are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Intracranial pressure management'</a>.)</p><p>Since ICP monitoring is associated with a small risk of serious complications, including central nervous system (CNS) infection and intracranial hemorrhage, it is reasonable to try to limit its use to patients most at risk of elevated ICP [<a href="#rid25">25</a>]. In general, invasive monitoring of ICP is indicated in patients who are [<a href="#rid26">26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Suspected to be at risk for elevated ICP</p><p class="bulletIndent1"><span class="glyph">●</span>Comatose (Glasgow Coma Scale [GCS] &lt;8) (<a class="graphic graphic_table graphicRef81854" href="/d/graphic/81854.html" rel="external">table 2</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Diagnosed with a process that merits aggressive medical care</p><p></p><p>Although computed tomography (CT) scans may suggest elevated ICP based on the presence of mass lesions, midline shift, or effacement of the basilar cisterns (<a class="graphic graphic_diagnosticimage graphicRef67017" href="/d/graphic/67017.html" rel="external">image 1</a>), patients without these findings on initial CT may have elevated ICP. This was demonstrated in a prospective study of 753 patients treated at four major head injury research centers in the United States, which found patients whose initial CT scan did not show a mass lesion, midline shift, or abnormal cisterns had a 10 to 15 percent chance of developing elevated ICP during their hospitalization [<a href="#rid27">27</a>].</p><p>Other studies have shown that up to one-third of patients with initially normal scans developed CT scan abnormalities within the first few days after closed head injury [<a href="#rid28">28,29</a>]. Together, these findings demonstrate that ICP can be elevated even in the setting of a normal initial CT, demonstrating the importance of invasive monitoring in high-risk patients and the role of follow-up imaging in patients who develop clinical evidence of increased ICP during hospitalization.</p><p class="headingAnchor" id="H12"><span class="h2">Types of monitors</span><span class="headingEndMark"> — </span>There are four main anatomic sites used in the clinical measurement of ICP: intraventricular, intraparenchymal, subarachnoid, and epidural (<a class="graphic graphic_figure graphicRef78630" href="/d/graphic/78630.html" rel="external">figure 5</a>) [<a href="#rid30">30</a>]. Noninvasive and metabolic monitoring of ICP has also been studied, but the clinical value of these methods is unclear at present. Each technique requires a unique monitoring system, and has associated advantages and disadvantages.</p><p class="headingAnchor" id="H13"><span class="h3">Intraventricular</span><span class="headingEndMark"> — </span>Intraventricular monitors are considered the "gold standard" of ICP monitoring catheters. They are surgically placed into the ventricular system and affixed to a drainage bag and pressure transducer with a three-way stopcock. Intraventricular monitoring has the advantage of accuracy, simplicity of measurement, and the unique characteristic of allowing for treatment of some causes of elevated ICP via drainage of cerebrospinal fluid (CSF).</p><p>The primary disadvantage is infection, which may occur in up to 20 percent of patients. This risk increases the longer a device is in place [<a href="#rid31">31,32</a>]. Prophylactic catheter changes did not appear to reduce the risk of infection [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/1286.html" rel="external">"Infections of cerebrospinal fluid shunts"</a>.)</p><p>A further disadvantage of intraventricular systems includes a small (approximately 2 percent) risk of hemorrhage during placement; this risk is greater in coagulopathic patients. In addition, it may be technically difficult to place an intraventricular drain into a small ventricle, particularly in the setting of trauma and cerebral edema complicated by ventricular compression [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H14"><span class="h3">Intraparenchymal</span><span class="headingEndMark"> — </span>Intraparenchymal devices consist of a thin cable with an electronic or fiberoptic transducer at the tip. The most widely used device is the fiberoptic Camino system. These monitors can be inserted directly into the brain parenchyma via a small hole drilled in the skull. Advantages include ease of placement and a lower risk of infection and hemorrhage (&lt;1 percent) than with intraventricular devices [<a href="#rid34">34-36</a>].</p><p>Disadvantages include the inability to drain CSF for diagnostic or therapeutic purposes and the potential to lose accuracy (or "drift") over several days, since the transducer cannot be recalibrated following initial placement [<a href="#rid30">30</a>]. In addition, there is a greater risk of mechanical failure due to the complex design of these monitors. The reliability of intraparenchymal devices has been debated. One group found only a small (1 mmHg) drift in a group of 163 patients [<a href="#rid37">37</a>]; however, a second report found that readings varied by &gt;3 mmHg in more than half of the 50 patients studied [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H15"><span class="h3">Subarachnoid</span><span class="headingEndMark"> — </span>Subarachnoid bolts are fluid-coupled systems within a hollow screw that can be placed through the skull adjacent to the dura. The dura is then punctured, which allows the CSF to communicate with the fluid column and transducer. The most commonly used subarachnoid monitor is the Richmond (or Becker) bolt; other types include the Philly bolt, the Leeds screw, and the Landy screw. These devices have low risk of infection and hemorrhage, but often clog with debris and are unreliable; therefore, they are rarely used. Additionally, they are believed to be less accurate than ventricular ICP devices [<a href="#rid30">30</a>].</p><p class="headingAnchor" id="H16"><span class="h3">Epidural</span><span class="headingEndMark"> — </span>Epidural monitors contain optical transducers that rest against the dura after passing through the skull. They often are inaccurate, as the dura damps the pressure transmitted to the epidural space, and thus are of limited clinical utility [<a href="#rid30">30,39</a>]. They are used in the management of coagulopathic patients with hepatic encephalopathy complicated by cerebral edema. In this setting, use of these catheters is associated with a significantly lower risk of intracerebral hemorrhage (4 versus 20 and 22 percent for intraparenchymal and intraventricular devices, respectively) and fatal hemorrhage (1 versus 5 and 4 percent, respectively) [<a href="#rid40">40</a>]. (See  <a class="medical medical_review" href="/d/html/3570.html" rel="external">"Acute liver failure in adults: Management and prognosis"</a>.)</p><p class="headingAnchor" id="H2314865"><span class="h2">Waveform analysis</span><span class="headingEndMark"> — </span>ICP is not a static value; it exhibits cyclic variation based on the superimposed effects of cardiac contraction, respiration, and intracranial compliance. Under normal physiologic conditions, the amplitude of the waveform is often small, with B waves related to respiration and smaller C waves (or Traube-Hering-Mayer waves) related to the cardiac cycle [<a href="#rid10">10</a>].</p><p>Pathological A waves (also called plateau waves) are abrupt, marked elevations in ICP of 50 to 100 mmHg, which usually last for minutes to hours (<a class="graphic graphic_waveform graphicRef61774" href="/d/graphic/61774.html" rel="external">waveform 1</a>). The presence of A waves signifies a loss of intracranial compliance and heralds imminent decompensation of autoregulatory mechanisms [<a href="#rid10">10,41,42</a>]. Thus, the presence of A waves should suggest the need for urgent intervention to help control ICP.</p><p class="headingAnchor" id="H17"><span class="h2">Noninvasive systems</span><span class="headingEndMark"> — </span>A number of devices designed to record ICP noninvasively have been studied, but most have not demonstrated reproducible clinical success or have not been studied in large clinical trials. We do not use these in clinical practice.</p><p class="bulletIndent1"><span class="glyph">●</span>Transcranial Doppler (TCD) measures the velocity of blood flow in the proximal cerebral circulation. TCD can be used to estimate ICP based on characteristic changes in waveforms that occur in response to increased resistance to cerebral blood flow (CBF) [<a href="#rid43">43,44</a>]. Generally, TCD is a poor predictor of ICP, although in trauma patients TCD findings may correlate with outcome at six months [<a href="#rid45">45-48</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tissue resonance analysis (TRA), an ultrasound-based method, has shown some promise. In one trial 40 patients underwent both invasive and TRA ICP monitoring, with good correlation between concomitant invasive and TRA measurements [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ocular sonography can provide a noninvasive measure of optic nerve sheath diameter, which has been found to correlate with ICP. A number of studies have found that diameters of 5 to 6 mm have the ability to discriminate between normal and elevated ICP in patients with intracranial hemorrhage and traumatic brain injury [<a href="#rid50">50-56</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intraocular pressure can be assessed noninvasively using an ultrasonic handheld optic tonometer. While some evidence suggests that intraocular pressure correlates with ICP in the absence of oculofacial trauma or glaucoma [<a href="#rid57">57</a>], most other studies' findings disagree [<a href="#rid58">58-60</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tympanic membrane displacement (measured using an impedance audiometer) has been compared to direct monitoring, based on the hypothesis that increased ICP will transmit a pressure wave to the tympanic membrane via the perilymph [<a href="#rid61">61,62</a>]. </p><p></p><p class="headingAnchor" id="H2314798"><span class="h2">Advanced neuromonitoring</span><span class="headingEndMark"> — </span>In order to supplement ICP monitoring, several technologies have been developed for the treatment of severe traumatic brain injury. These techniques allow for the measurement of cerebral physiologic and metabolic parameters related to oxygen delivery, CBF, and metabolism with the goal of improving the detection and management of secondary brain injury. These are discussed separately. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Advanced neuromonitoring'</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">GENERAL MANAGEMENT</span><span class="headingEndMark"> — </span>The best therapy for intracranial hypertension (ICH) is resolution of the proximate cause of elevated ICP. Examples include evacuation of a blood clot, resection of a tumor, cerebrospinal fluid (CSF) diversion in the setting of hydrocephalus, or treatment of an underlying metabolic disorder.</p><p>Regardless of the cause, ICH is a medical emergency, and treatment should be undertaken as expeditiously as possible. In addition to definitive therapy, there are maneuvers that can be employed to reduce ICP acutely. Some of these techniques are generally applicable to all patients with suspected ICH; others (particularly glucocorticoids) are reserved for specific causes of ICH.</p><p class="headingAnchor" id="H20"><span class="h2">Resuscitation</span><span class="headingEndMark"> — </span>The urgent assessment and support of oxygenation, blood pressure (BP), and end-organ perfusion are particularly important in trauma, but applicable to all patients [<a href="#rid63">63-65</a>]. If elevated ICP is suspected, care should be taken to minimize further elevations in ICP during intubation through careful positioning, appropriate choice of paralytic agents (if required), and adequate sedation. Pretreatment with <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> has been suggested as a useful intervention to decrease the rise in ICP associated with intubation; however, good clinical evidence supporting this approach is limited [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/d/html/7956.html" rel="external">"Overview of inpatient management of the adult trauma patient"</a> and  <a class="medical medical_review" href="/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults"</a> and  <a class="medical medical_review" href="/d/html/272.html" rel="external">"Adult basic life support (BLS) for health care providers"</a>.)</p><p>Large shifts in BP should be minimized, with particular care taken to avoid hypotension. Although it might seem that lower BP would result in lower ICP, this is not the case. Hypotension, especially in conjunction with hypoxemia, can induce reactive vasodilation and elevations in ICP. As noted above, pressors have been shown to be safe for use in most patients with ICH, and may be required to maintain cerebral perfusion pressure (CPP) &gt;60 mmHg [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/1619.html" rel="external">"Use of vasopressors and inotropes"</a>.)</p><p class="headingAnchor" id="H21"><span class="h2">Urgent situations</span><span class="headingEndMark"> — </span>Life-saving measures may need to be instituted prior to a more detailed workup (eg, imaging or ICP monitoring) in a patient who presents acutely with history or examination findings suggestive of elevated ICP. Many of these situations will rely upon clinical judgment, but the following combination of findings suggests the need for urgent intervention [<a href="#rid67">67,68</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A history that suggests elevated ICP (eg, head trauma, sudden severe headache typical of subarachnoid hemorrhage)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An examination that suggests elevated ICP (unilateral or bilaterally fixed and dilated pupil[s], decorticate or decerebrate posturing, bradycardia, hypertension and/or respiratory depression)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A Glasgow Coma Scale (GCS) ≤8</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Potentially confounding and reversible causes of depressed mental status, such as hypotension (systolic BP [SBP] &lt;60 mmHg in adults), hypoxemia (PaO<sub>2</sub> &lt;60 mmHg), hypothermia (&lt;36ºC), or obvious intoxication, are absent</p><p></p><p>In such patients, osmotic diuretics may be used urgently. (See <a class="local">'Mannitol'</a> below.)</p><p>In addition, standard resuscitation techniques should be instituted as soon as possible:</p><p class="bulletIndent1"><span class="glyph">●</span>Head elevation</p><p class="bulletIndent1"><span class="glyph">●</span>Hyperventilation to a PCO<sub>2</sub> of 26 to 30 mmHg</p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a> (1 to 1.5 g/kg)</p><p></p><p>Concomitant with these measures should be aggressive evaluation of the underlying diagnosis, including neuroimaging, detailed neurologic examination, and history gathering. Hyperventilation may be contraindicated in the setting of traumatic brain injury and acute stroke, and is discussed separately (see <a class="local">'Hyperventilation'</a> below). If appropriate, ventriculostomy is a rapid means of simultaneously diagnosing and treating elevated ICP.</p><p class="headingAnchor" id="H22"><span class="h2">Monitoring and the decision to treat</span><span class="headingEndMark"> — </span>If a diagnosis of elevated ICP is suspected and an immediately treatable proximate cause is not present, then ICP monitoring should be instituted. The use of ICP monitoring is associated with decreased mortality in patients with traumatic brain injury [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Intracranial pressure management'</a>.)</p><p>The type of monitoring device employed should be based on an assessment of the advantages and disadvantages discussed previously (<a class="graphic graphic_figure graphicRef78630" href="/d/graphic/78630.html" rel="external">figure 5</a>). (See <a class="local">'ICP monitoring'</a> above.)</p><p>The goal of ICP monitoring and treatment should be to keep ICP &lt;20 mmHg [<a href="#rid69">69</a>]. Interventions should be utilized only when ICP is elevated above 20 mmHg for &gt;5 to 10 minutes. As discussed above, brief physiologic elevations in ICP may occur in the setting of coughing, movement, suctioning, or ventilator asynchrony.</p><p class="headingAnchor" id="H23"><span class="h2">Fluid management</span><span class="headingEndMark"> — </span>In general, patients with elevated ICP do not need to be severely fluid restricted [<a href="#rid70">70</a>]. Patients should be kept euvolemic and normo- to hyperosmolar. This can be achieved by avoiding all free water (including D5W, 0.45 percent [half normal] <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>, and enteral free water) and employing only isotonic fluids (such as 0.9 percent [normal] saline). Serum osmolality should be kept &gt;280 mOsm/L, and often is kept in the 295 to 305 mOsm/L range. Hyponatremia is common in the setting of elevated ICP, particularly in conjunction with subarachnoid hemorrhage. (See  <a class="medical medical_review" href="/d/html/2374.html" rel="external">"Causes of hypotonic hyponatremia in adults"</a> and  <a class="medical medical_review" href="/d/html/2357.html" rel="external">"Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat", section on 'Subarachnoid hemorrhage'</a>.)</p><p>Similarly, the value of colloid compared with crystalloid fluid resuscitation in patients with elevated ICP has been studied, but findings have been inconclusive with respect to the superior approach [<a href="#rid71">71</a>]. A subgroup analysis in one large study, however, suggested that in patients with traumatic brain injury, fluid resuscitation with albumin was associated with a higher mortality as compared with normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> [<a href="#rid72">72</a>]. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury"</a>.)</p><p>Hypertonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> in bolus doses may acutely lower ICP, but further investigations are required to define a role, if any, for this approach in the management of elevated ICP. (See <a class="local">'Hypertonic saline bolus'</a> below.)</p><p class="headingAnchor" id="H24"><span class="h2">Sedation</span><span class="headingEndMark"> — </span>Keeping patients appropriately sedated can decrease ICP by reducing metabolic demand, ventilator asynchrony, venous congestion, and the sympathetic responses of hypertension and tachycardia [<a href="#rid73">73</a>]. Establishing a secure airway and close attention to BP allow the clinician to identify and treat apnea and hypotension quickly.</p><p><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a> has been utilized to good effect in this setting, as it is easily titrated and has a short half-life, thus permitting frequent neurologic reassessment. (See  <a class="medical medical_review" href="/d/html/1606.html" rel="external">"Sedative-analgesia in ventilated adults: Management strategies, agent selection, monitoring, and withdrawal"</a>.)</p><p class="headingAnchor" id="H25"><span class="h2">Blood pressure control</span><span class="headingEndMark"> — </span>In general, BP should be sufficient to maintain CPP &gt;60 mmHg. As discussed above, pressors can be used safely without further increasing ICP. This is particularly relevant in the setting of sedation, when iatrogenic hypotension can occur. Hypertension should generally only be treated when CPP &gt;120 mmHg and ICP &gt;20 mmHg.</p><p>Caution should be taken to avoid CPP &lt;50 mmHg or, as noted above, normalization of BP in patients with chronic hypertension in whom the autoregulatory curve has shifted to the right (see <a class="local">'Autoregulation'</a> above). General issues regarding BP management following stroke are presented elsewhere. (See  <a class="medical medical_review" href="/d/html/3823.html" rel="external">"Antihypertensive therapy for secondary stroke prevention"</a>.)</p><p class="headingAnchor" id="H26"><span class="h2">Position</span><span class="headingEndMark"> — </span>Patients with elevated ICP should be positioned to maximize venous outflow from the head. Important maneuvers include reducing excessive flexion or rotation of the neck, avoiding restrictive neck taping, and minimizing stimuli that could induce Valsalva responses, such as endotracheal suctioning.</p><p>Patients with elevated ICP have historically been positioned with the head elevated above the heart (usually 30 degrees) to increase venous outflow. It should be noted that head elevation may lower CPP [<a href="#rid20">20,74</a>]; however, given the proven efficacy of head elevation in lowering ICP, most experts recommend raising the patient's head as long as the CPP remains at an appropriate level [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H27"><span class="h2">Fever</span><span class="headingEndMark"> — </span>Elevated metabolic demand in the brain results in increased cerebral blood flow (CBF) and can elevate ICP by increasing the volume of blood in the cranial vault. Conversely, decreasing metabolic demand can lower ICP by reducing blood flow.</p><p>Fever increases brain metabolism and has been demonstrated to increase brain injury in animal models [<a href="#rid76">76</a>]. Therefore, aggressive treatment of fever, including <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a> and mechanical cooling, is recommended in patients with increased ICP. ICH is a recognized indication for neuromuscular paralysis in selected patients [<a href="#rid77">77</a>]. (See  <a class="medical medical_review" href="/d/html/1590.html" rel="external">"Neuromuscular blocking agents in critically ill patients: Use, agent selection, administration, and adverse effects"</a>.)</p><p class="headingAnchor" id="H28"><span class="h2">Antiseizure therapy</span><span class="headingEndMark"> — </span>Seizures can both complicate and contribute to elevated ICP [<a href="#rid78">78,79</a>]. Anticonvulsant therapy should be instituted if seizures are suspected; prophylactic treatment may be warranted in some cases. There are no clear guidelines for the latter, but examples include high-risk mass lesions, such as those within supratentorial cortical locations, or lesions adjacent to the cortex, such as subdural hematomas or subarachnoid hemorrhage.</p><p class="headingAnchor" id="H29"><span class="h1">SPECIFIC THERAPIES</span><span class="headingEndMark"> — </span>As mentioned previously, the best treatment of elevated ICP is to address its underlying cause. If this is not possible, a series of steps should be instituted to reduce ICP in an attempt to improve outcome. In all cases, the clinician should bear in mind the themes of resuscitation, reduction of intracranial volume, and frequent reevaluation discussed above.</p><p class="headingAnchor" id="H267641463"><span class="h2">Osmotic therapy and diuresis</span><span class="headingEndMark"> — </span>With growing familiarity of use, hypertonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> has increasingly been employed as a first-line agent, supplanting <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a> at numerous institutions.</p><p class="headingAnchor" id="H3762927779"><span class="h3">Hypertonic saline bolus</span><span class="headingEndMark"> — </span>Hypertonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> in bolus doses can acutely lower ICP; however, the effect of this early intervention on long-term clinical outcomes remains unclear [<a href="#rid80">80-88</a>]. The volume and tonicity of saline (7.2 to 23.4 percent) used in these reports have varied widely. As an example, one controlled trial randomly assigned 226 patients with traumatic brain injury to prehospital resuscitation with 250 mL hypertonic saline (7.5 percent) or the same volume of Ringer's lactate [<a href="#rid80">80</a>]. Survival until hospital discharge, six-month survival, and neurologic function six months after injury were similar in both groups. In a retrospective review of patients treated at a single study, the safety and efficacy of 14.6 and 23.4 percent saline boluses appeared to be similar [<a href="#rid89">89</a>].</p><p><a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">Mannitol</a> and hypertonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> have been compared in at least eight randomized trials of patients with elevated ICP from a variety of causes (traumatic brain injury, stroke, tumors) [<a href="#rid87">87,90-93</a>]. Meta-analyses of these trials have found that hypertonic saline appears to have greater efficacy in managing elevated ICP, but clinical outcomes have not been systematically examined [<a href="#rid94">94,95</a>]. Further clinical trials are required to clarify the appropriate role of hypertonic saline infusion versus mannitol in the management of elevated ICP [<a href="#rid96">96,97</a>]. </p><p>The role of hypertonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> in the management of elevated ICP in traumatic brain injury is discussed separately. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Osmotic therapy'</a>.)</p><p class="headingAnchor" id="H30"><span class="h3">Mannitol</span><span class="headingEndMark"> — </span>Osmotic diuretics reduce brain volume by drawing free water out of the tissue and into the circulation, where it is excreted by the kidneys, thus dehydrating brain parenchyma [<a href="#rid98">98-101</a>]. The most commonly used agent is <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a>. It is prepared as a 20 percent solution, and given as a bolus of 1 g/kg. Repeat dosing can be given at 0.25 to 0.5 g/kg as needed, generally every six to eight hours. Use of any osmotic agent should be carefully evaluated in patients with renal insufficiency.</p><p>The effects are usually present within minutes, peak at approximately one hour, and last 4 to 24 hours [<a href="#rid26">26,102</a>]. Some have reported a "rebound" increase in ICP; this probably occurs when <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a>, after repeated use, enters the brain though a damaged blood-brain barrier and reverses the osmotic gradient [<a href="#rid103">103,104</a>]. Useful parameters to monitor in the setting of mannitol therapy include serum sodium, serum osmolality, and renal function.</p><p>Concerning findings associated with the use of <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a> include serum sodium &gt;150 mEq, serum osmolality &gt;320 mOsm, or evidence of evolving acute tubular necrosis (ATN). In addition, mannitol can lower systemic blood pressure (BP), necessitating careful use if associated with a fall in cerebral perfusion pressure (CPP). Patients with known renal disease may be poor candidates for osmotic diuresis. (See  <a class="medical medical_review" href="/d/html/2333.html" rel="external">"Complications of mannitol therapy"</a>.)</p><p class="headingAnchor" id="H267641559"><span class="h3">Other agents</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8482" href="/d/drug information/8482.html" rel="external">Furosemide</a>, 0.5 to 1.0 mg/kg intravenously, may be given with <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a> to potentiate its effect. However, this effect can also exacerbate dehydration and hypokalemia [<a href="#rid105">105-107</a>].</p><p>Glycerol and urea were used historically to control ICP via osmoregulation; however, use of these agents has decreased because equilibration between brain and plasma levels occurs more quickly than with <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a>. Furthermore, glycerol has been shown to have a significant rebound effect and to be less effective in ICP control [<a href="#rid108">108,109</a>].</p><p class="headingAnchor" id="H33"><span class="h2">Glucocorticoids</span><span class="headingEndMark"> — </span>Glucocorticoids were associated with a worse outcome in a large randomized clinical trial of their use in moderate to severe head injury [<a href="#rid110">110,111</a>]. They should not be used in this setting. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury"</a>.)</p><p>In addition, glucocorticoids are not considered to be useful in the management of cerebral infarction or intracranial hemorrhage. (See  <a class="medical medical_review" href="/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis"</a>.)</p><p>By contrast, glucocorticoids may have a role in the setting of intracranial hypertension (ICH) caused by brain tumors and central nervous system (CNS) infections. (See  <a class="medical medical_review" href="/d/html/5182.html" rel="external">"Management of vasogenic edema in patients with primary and metastatic brain tumors"</a> and  <a class="medical medical_review" href="/d/html/1279.html" rel="external">"Treatment and prognosis of bacterial brain abscess"</a> and  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a>.)</p><p class="headingAnchor" id="H34"><span class="h2">Hyperventilation</span><span class="headingEndMark"> — </span>Use of mechanical ventilation to lower PaCO<sub>2</sub> to 26 to 30 mmHg has been shown to rapidly reduce ICP through vasoconstriction and a decrease in the volume of intracranial blood; a 1 mmHg change in PaCO<sub>2</sub> is associated with a 3 percent change in cerebral blood flow (CBF) [<a href="#rid112">112</a>]. Hyperventilation also results in respiratory alkalosis, which may buffer post-injury acidosis [<a href="#rid112">112</a>]. The effect of hyperventilation on ICP is short-lived (1 to 24 hours) [<a href="#rid113">113-115</a>]. Following therapeutic hyperventilation, the patient's respiratory rate should be tapered back to normal over several hours to avoid a rebound effect [<a href="#rid116">116</a>].</p><p>Therapeutic hyperventilation should be considered as an urgent intervention when elevated ICP complicates cerebral edema, intracranial hemorrhage, and tumor. Hyperventilation should not be used on a chronic basis, regardless of the cause of increased ICP.</p><p>Hyperventilation should be minimized in patients with traumatic brain injury or acute stroke. In these settings, vasoconstriction may cause a critical decrease in local cerebral perfusion and worsen neurologic injury, particularly in the first 24 to 48 hours [<a href="#rid24">24,113,115,117-120</a>]. Thus, the need for hyperventilation should be carefully considered, and prophylactic hyperventilation in the absence of elevated ICP should be avoided. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Ventilation'</a>.)</p><p class="headingAnchor" id="H35"><span class="h2">Barbiturates</span><span class="headingEndMark"> — </span>The use of barbiturates is predicated on their ability to reduce brain metabolism and CBF, thus lowering ICP and exerting a neuroprotective effect [<a href="#rid121">121-124</a>]. <a class="drug drug_general" data-topicid="9754" href="/d/drug information/9754.html" rel="external">Pentobarbital</a> is generally used, with a loading dose of 5 to 20 mg/kg as a bolus, followed by 1 to 4 mg/kg per hour [<a href="#rid125">125,126</a>]. Treatment should be assessed based on ICP, CPP, and the presence of unacceptable side effects. Continuous electroencephalography (EEG) monitoring is generally used; EEG burst suppression is an indication of maximal dosing.</p><p>The therapeutic value of this maneuver is somewhat unclear. In a randomized trial of 73 patients with elevations in ICP refractory to standard therapy, patients treated with <a class="drug drug_general" data-topicid="9754" href="/d/drug information/9754.html" rel="external">pentobarbital</a> were 50 percent more likely to have their ICP controlled. However, there was no difference in clinical outcomes between groups [<a href="#rid127">127</a>]. In general, the use of barbiturates is a "last-ditch" effort, as several studies show that their ability to lower ICP does not appear to affect outcomes [<a href="#rid112">112,128</a>].</p><p>Barbiturate therapy can be complicated by hypotension, possibly requiring vasopressor support. The use of barbiturates is also associated with a loss of the neurologic examination, requiring accurate ICP, hemodynamic, and often EEG monitoring to guide therapy. In this setting, thiopental has been reported to produce hypokalemia with induction and rebound hyperkalemia on drug cessation [<a href="#rid129">129</a>]. </p><p class="headingAnchor" id="H36"><span class="h2">Therapeutic hypothermia</span><span class="headingEndMark"> — </span>First reported as a treatment for brain injury in the 1950s, induced or therapeutic hypothermia has remained a controversial issue in the debate concerning the management of elevated ICP [<a href="#rid112">112,130,131</a>]. It is not currently recommended as a standard treatment for increased ICP in any clinical setting.</p><p>Hypothermia decreases cerebral metabolism and may reduce CBF and ICP. Initial studies of hypothermia were limited by systemic side effects, including cardiac arrhythmias and severe coagulopathy. However, later work suggested that hypothermia can lower ICP and may improve patient outcomes [<a href="#rid132">132</a>]. Hypothermia also appeared to be effective in lowering ICP after other therapies have failed [<a href="#rid133">133,134</a>].</p><p>Hypothermia can be achieved using whole-body cooling, including lavage and cooling blankets, to a goal core temperature of 32 to 34ºC. The best method of cooling (local versus systemic), the optimal target core temperature, and the appropriate duration of treatment are not known [<a href="#rid135">135</a>]. It appears that rewarming should be accomplished over a period of less than 24 hours [<a href="#rid136">136</a>].</p><p>The value of therapeutic hypothermia has been best assessed in patients after traumatic brain injury, but its role has not been well established in that setting. (See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Hypothermia'</a> and  <a class="medical medical_review" href="/d/html/106112.html" rel="external">"Elevated intracranial pressure (ICP) in children: Management", section on 'Temperature control'</a>.)</p><p>Given the uncertainties surrounding the appropriate use of therapeutic hypothermia in patients with elevated ICP, this treatment should be limited to clinical trials, or to patients with ICH refractory to other therapies.</p><p class="headingAnchor" id="H37"><span class="h2">Removal of CSF</span><span class="headingEndMark"> — </span>When hydrocephalus is identified, a ventriculostomy should be inserted (<a class="graphic graphic_figure graphicRef56391" href="/d/graphic/56391.html" rel="external">figure 6</a>). Rapid aspiration of cerebrospinal fluid (CSF) should be avoided because it may lead to obstruction of the catheter opening by brain tissue. Also, in patients with aneurysmal subarachnoid hemorrhage, abrupt lowering of the pressure differential across the aneurysm dome can precipitate recurrent hemorrhage.</p><p>CSF should be removed at a rate of approximately 1 to 2 mL/minute, for two to three minutes at a time, with intervals of two to three minutes in between until a satisfactory ICP has been achieved (ICP &lt;20 mmHg) or until CSF is no longer easily obtained. Slow removal can also be accomplished by passive gravitational drainage through the ventriculostomy. A lumbar drain is generally contraindicated in the setting of high ICP due to the risk of transtentorial herniation.</p><p class="headingAnchor" id="H38"><span class="h2">Decompressive craniectomy</span><span class="headingEndMark"> — </span>Decompressive craniectomy removes the rigid confines of the bony skull, increasing the potential volume of the intracranial contents and circumventing the Monroe-Kellie doctrine. There is a growing body of literature supporting the efficacy of decompressive craniectomy in certain clinical situations [<a href="#rid137">137-146</a>]. Importantly, it has been demonstrated that in patients with elevated ICP, craniectomy alone lowered ICP 15 percent, but opening the dura in addition to the bony skull resulted in an average decrease in ICP of 70 percent [<a href="#rid147">147</a>]. Decompressive craniectomy also appears to improve brain tissue oxygenation [<a href="#rid148">148</a>].</p><p>Observational data suggest that rapid and sustained control of ICP, including the use of decompressive craniectomy, improves outcomes in trauma, stroke, and subarachnoid hemorrhage in carefully selected cases [<a href="#rid149">149-156</a>]. The indications for decompressive craniectomy in these settings are discussed separately (see  <a class="medical medical_review" href="/d/html/1096.html" rel="external">"Malignant cerebral hemispheric infarction with swelling and risk of herniation"</a> and  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Decompressive craniectomy'</a>). Obvious mass lesions associated with an elevated ICP should be removed, if possible.</p><p>Potential complications of surgery include herniation through the skull defect, spinal fluid leak, wound infection, and epidural and subdural hematoma [<a href="#rid157">157</a>].</p><p>Paradoxical transtentorial herniation is an uncommon but potentially lethal complication in patients with hemicraniectomy and a large skull defect who subsequently undergo lumbar puncture (LP) or CSF drainage [<a href="#rid158">158,159</a>]. This results from the combined effects of atmospheric pressure with the negative pressure of the LP or ventriculostomy. It has also been described as a delayed complication three to five months after decompressive craniectomy for cerebral infarction in the absence of LP or ventriculostomy [<a href="#rid160">160</a>]. Marked decompression of the skin and dura over the skull defect accompanies and may precede neurologic signs of herniation. Standard treatments to lower ICP can hasten herniation. Instead, the patient should be placed supine or in the Trendelenburg position, CSF drains should be clamped, crystalloid fluid should be administered intravenously, and an epidural blood patch placed for patients with dural leak.</p><p class="headingAnchor" id="H39"><span class="h1">SUMMARY</span><span class="headingEndMark"> — </span>The best therapy for intracranial hypertension (ICH) is resolution of the proximate cause of elevated ICP. Regardless of the cause, treatment should be undertaken as expeditiously as possible, and should be based on the principles of resuscitation, reduction of the volume of the intracranial contents, and reassessment. Interventions should be based on careful assessment of the individual clinical scenario rather than on strict protocols. Specific recommendations regarding the assessment and treatment of elevated intracranial pressure (ICP) in individual disease settings, including trauma, cerebrovascular disease, and other conditions, are discussed separately. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury", section on 'Intracranial pressure management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Intracranial pressure management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1107.html" rel="external">"Intracranial epidural hematoma in adults", section on 'Intracranial pressure'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1110.html" rel="external">"Subdural hematoma in adults: Management and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1096.html" rel="external">"Malignant cerebral hemispheric infarction with swelling and risk of herniation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1109.html" rel="external">"Cerebral venous thrombosis: Treatment and prognosis", section on 'Elevated intracranial pressure and herniation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5182.html" rel="external">"Management of vasogenic edema in patients with primary and metastatic brain tumors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1291.html" rel="external">"Neurologic complications of bacterial meningitis in adults", section on 'Increased intracranial pressure'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/85376.html" rel="external">"Clinical management and monitoring during antifungal therapy for cryptococcal meningoencephalitis in persons with HIV", section on 'Monitoring of intracranial pressure'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3570.html" rel="external">"Acute liver failure in adults: Management and prognosis", section on 'Cerebral edema'</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Adams RA, Ropper AH. Principles of neurology, 6th ed, McGraw Hill, New York 1997.</li><li><a class="nounderline abstract_t">Welch K. The intracranial pressure in infants. J Neurosurg 1980; 52:693.</a></li><li class="breakAll">Kaye AH. Brain Tumors: An Encyclopedic Approach, 2nd ed, Churchill Livingstone, New York 2001. p.205.</li><li class="breakAll">Monro A. Observations in the structure and functions of the nervous system, Creech and Johnson, Edinburgh 1783.</li><li><a class="nounderline abstract_t">Kellie G. An account of the appearence observed in the dissection of two of the individuals presumed to have perished in the storm of the third, and whose bodies were discovered in the vicinity of Leith on the morning of the 24th, November 1821; with some reflections on the pathology of the brain. Trans Med Chir Soc (Edinburgh) 1821-1832; 1:84.</a></li><li class="breakAll">Fishman R. Cerebrospinal fluid in diseases of the nervous system, WB Saunders, Philadelphia 1980.</li><li><a class="nounderline abstract_t">Bruce DA, Alavi A, Bilaniuk L, et al. Diffuse cerebral swelling following head injuries in children: the syndrome of "malignant brain edema". J Neurosurg 1981; 54:170.</a></li><li><a class="nounderline abstract_t">Aldrich EF, Eisenberg HM, Saydjari C, et al. Diffuse brain swelling in severely head-injured children. A report from the NIH Traumatic Coma Data Bank. J Neurosurg 1992; 76:450.</a></li><li><a class="nounderline abstract_t">Levin HS, Aldrich EF, Saydjari C, et al. Severe head injury in children: experience of the Traumatic Coma Data Bank. Neurosurgery 1992; 31:435.</a></li><li class="breakAll">Wilkins RS. Neurosurgery, 2nd ed, McGraw-Hill, New York 1996. Vol 1, p.347.</li><li><a class="nounderline abstract_t">Strandgaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 1989; 2:486.</a></li><li><a class="nounderline abstract_t">Strandgaard S, Andersen GS, Ahlgreen P, Nielsen PE. Visual disturbances and occipital brain infarct following acute, transient hypotension in hypertensive patients. Acta Med Scand 1984; 216:417.</a></li><li><a class="nounderline abstract_t">Enevoldsen EM, Jensen FT. Autoregulation and CO2 responses of cerebral blood flow in patients with acute severe head injury. J Neurosurg 1978; 48:689.</a></li><li><a class="nounderline abstract_t">Lassen NA, Agnoli A. The upper limit of autoregulation of cerebral blood flow--on the pathogenesis of hypertensive encepholopathy. Scand J Clin Lab Invest 1972; 30:113.</a></li><li><a class="nounderline abstract_t">Kaplan NM. Management of hypertensive emergencies. Lancet 1994; 344:1335.</a></li><li><a class="nounderline abstract_t">Hadjikoutis S, Carroll C, Plant GT. Raised intracranial pressure presenting with spontaneous periorbital bruising: two case reports. J Neurol Neurosurg Psychiatry 2004; 75:1192.</a></li><li class="breakAll">Plum F, Posner J. The Diagnosis of Stupor and Coma, 3rd ed, FA Davis, Philadelphia 1980.</li><li><a class="nounderline abstract_t">Kernohan JW. Incisura of the crus due to contralateral brain tumor. Arch Neurol Psychiatry 1929; 21:274.</a></li><li><a class="nounderline abstract_t">Binder DK, Lyon R, Manley GT. Transcranial motor evoked potential recording in a case of Kernohan's notch syndrome: case report. Neurosurgery 2004; 54:999.</a></li><li><a class="nounderline abstract_t">Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg 1995; 83:949.</a></li><li><a class="nounderline abstract_t">Lane PL, Skoretz TG, Doig G, Girotti MJ. Intracranial pressure monitoring and outcomes after traumatic brain injury. Can J Surg 2000; 43:442.</a></li><li><a class="nounderline abstract_t">Bulger EM, Nathens AB, Rivara FP, et al. Management of severe head injury: institutional variations in care and effect on outcome. Crit Care Med 2002; 30:1870.</a></li><li><a class="nounderline abstract_t">Mauritz W, Steltzer H, Bauer P, et al. Monitoring of intracranial pressure in patients with severe traumatic brain injury: an Austrian prospective multicenter study. Intensive Care Med 2008; 34:1208.</a></li><li><a class="nounderline abstract_t">Marik PE, Varon J, Trask T. Management of head trauma. Chest 2002; 122:699.</a></li><li class="breakAll">Bullock R, Chesnut RM, Clifton G. Guidelines for the Management of Severe Brain Injury, Brain Trauma Foundation/American Association of Neurologic Surgeons, New York 1995.</li><li><a class="nounderline abstract_t">Dennis LJ, Mayer SA. Diagnosis and management of increased intracranial pressure. Neurol India 2001; 49 Suppl 1:S37.</a></li><li><a class="nounderline abstract_t">Eisenberg HM, Gary HE Jr, Aldrich EF, et al. Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J Neurosurg 1990; 73:688.</a></li><li><a class="nounderline abstract_t">O'Sullivan MG, Statham PF, Jones PA, et al. Role of intracranial pressure monitoring in severely head-injured patients without signs of intracranial hypertension on initial computerized tomography. J Neurosurg 1994; 80:46.</a></li><li><a class="nounderline abstract_t">Lobato RD, Sarabia R, Rivas JJ, et al. Normal computerized tomography scans in severe head injury. Prognostic and clinical management implications. J Neurosurg 1986; 65:784.</a></li><li><a class="nounderline abstract_t">Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al. Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure monitoring technology. J Neurotrauma 2007; 24 Suppl 1:S45.</a></li><li><a class="nounderline abstract_t">Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med 1984; 310:553.</a></li><li><a class="nounderline abstract_t">Holloway KL, Barnes T, Choi S, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg 1996; 85:419.</a></li><li><a class="nounderline abstract_t">Ghajar J. Intracranial pressure monitoring techniques. New Horiz 1995; 3:395.</a></li><li><a class="nounderline abstract_t">Ostrup RC, Luerssen TG, Marshall LF, Zornow MH. Continuous monitoring of intracranial pressure with a miniaturized fiberoptic device. J Neurosurg 1987; 67:206.</a></li><li><a class="nounderline abstract_t">Gambardella G, d'Avella D, Tomasello F. Monitoring of brain tissue pressure with a fiberoptic device. Neurosurgery 1992; 31:918.</a></li><li><a class="nounderline abstract_t">Bochicchio M, Latronico N, Zappa S, et al. Bedside burr hole for intracranial pressure monitoring performed by intensive care physicians. A 5-year experience. Intensive Care Med 1996; 22:1070.</a></li><li><a class="nounderline abstract_t">Poca MA, Sahuquillo J, Arribas M, et al. Fiberoptic intraparenchymal brain pressure monitoring with the Camino V420 monitor: reflections on our experience in 163 severely head-injured patients. J Neurotrauma 2002; 19:439.</a></li><li><a class="nounderline abstract_t">Piper I, Barnes A, Smith D, Dunn L. The Camino intracranial pressure sensor: is it optimal technology? An internal audit with a review of current intracranial pressure monitoring technologies. Neurosurgery 2001; 49:1158.</a></li><li><a class="nounderline abstract_t">Miller JD, Bobo H, Kapp JP. Inaccurate pressure readings for subarachnoid bolts. Neurosurgery 1986; 19:253.</a></li><li><a class="nounderline abstract_t">Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341:157.</a></li><li><a class="nounderline abstract_t">Hayashi M, Handa Y, Kobayashi H, et al. Plateau-wave phenomenon (I). Correlation between the appearance of plateau waves and CSF circulation in patients with intracranial hypertension. Brain 1991; 114 ( Pt 6):2681.</a></li><li><a class="nounderline abstract_t">Rosner MJ, Becker DP. Origin and evolution of plateau waves. Experimental observations and a theoretical model. J Neurosurg 1984; 60:312.</a></li><li><a class="nounderline abstract_t">Manno EM. Transcranial Doppler ultrasonography in the neurocritical care unit. Crit Care Clin 1997; 13:79.</a></li><li><a class="nounderline abstract_t">Edouard AR, Vanhille E, Le Moigno S, et al. Non-invasive assessment of cerebral perfusion pressure in brain injured patients with moderate intracranial hypertension. Br J Anaesth 2005; 94:216.</a></li><li><a class="nounderline abstract_t">Hassler W, Steinmetz H, Gawlowski J. Transcranial Doppler ultrasonography in raised intracranial pressure and in intracranial circulatory arrest. J Neurosurg 1988; 68:745.</a></li><li><a class="nounderline abstract_t">Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57:769.</a></li><li><a class="nounderline abstract_t">Tan H, Feng H, Gao L, et al. Outcome prediction in severe traumatic brain injury with transcranial Doppler ultrasonography. Chin J Traumatol 2001; 4:156.</a></li><li><a class="nounderline abstract_t">Kristiansson H, Nissborg E, Bartek J Jr, et al. Measuring elevated intracranial pressure through noninvasive methods: a review of the literature. J Neurosurg Anesthesiol 2013; 25:372.</a></li><li><a class="nounderline abstract_t">Michaeli D, Rappaport ZH. Tissue resonance analysis; a novel method for noninvasive monitoring of intracranial pressure. Technical note. J Neurosurg 2002; 96:1132.</a></li><li><a class="nounderline abstract_t">Soldatos T, Karakitsos D, Chatzimichail K, et al. Optic nerve sonography in the diagnostic evaluation of adult brain injury. Crit Care 2008; 12:R67.</a></li><li><a class="nounderline abstract_t">Moretti R, Pizzi B, Cassini F, Vivaldi N. Reliability of optic nerve ultrasound for the evaluation of patients with spontaneous intracranial hemorrhage. Neurocrit Care 2009; 11:406.</a></li><li><a class="nounderline abstract_t">Moretti R, Pizzi B. Optic nerve ultrasound for detection of intracranial hypertension in intracranial hemorrhage patients: confirmation of previous findings in a different patient population. J Neurosurg Anesthesiol 2009; 21:16.</a></li><li><a class="nounderline abstract_t">Dubourg J, Javouhey E, Geeraerts T, et al. Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis. Intensive Care Med 2011; 37:1059.</a></li><li><a class="nounderline abstract_t">Geeraerts T, Launey Y, Martin L, et al. Ultrasonography of the optic nerve sheath may be useful for detecting raised intracranial pressure after severe brain injury. Intensive Care Med 2007; 33:1704.</a></li><li><a class="nounderline abstract_t">Geeraerts T, Merceron S, Benhamou D, et al. Non-invasive assessment of intracranial pressure using ocular sonography in neurocritical care patients. Intensive Care Med 2008; 34:2062.</a></li><li><a class="nounderline abstract_t">Kimberly HH, Shah S, Marill K, Noble V. Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure. Acad Emerg Med 2008; 15:201.</a></li><li><a class="nounderline abstract_t">Lashutka MK, Chandra A, Murray HN, et al. The relationship of intraocular pressure to intracranial pressure. Ann Emerg Med 2004; 43:585.</a></li><li><a class="nounderline abstract_t">Sheeran P, Bland JM, Hall GM. Intraocular pressure changes and alterations in intracranial pressure. Lancet 2000; 355:899.</a></li><li><a class="nounderline abstract_t">Han Y, McCulley TJ, Horton JC. No correlation between intraocular pressure and intracranial pressure. Ann Neurol 2008; 64:221.</a></li><li><a class="nounderline abstract_t">Kirk T, Jones K, Miller S, Corbett J. Measurement of intraocular and intracranial pressure: is there a relationship? Ann Neurol 2011; 70:323.</a></li><li><a class="nounderline abstract_t">Kast R. A new method for noninvasive measurement of short-term cerebrospinal fluid pressure changes in humans. J Neurol 1985; 232:260.</a></li><li><a class="nounderline abstract_t">Reid A, Marchbanks RJ, Bateman DE, et al. Mean intracranial pressure monitoring by a non-invasive audiological technique: a pilot study. J Neurol Neurosurg Psychiatry 1989; 52:610.</a></li><li><a class="nounderline abstract_t">Procaccio F, Stocchetti N, Citerio G, et al. Guidelines for the treatment of adults with severe head trauma (part I). Initial assessment; evaluation and pre-hospital treatment; current criteria for hospital admission; systemic and cerebral monitoring. J Neurosurg Sci 2000; 44:1.</a></li><li><a class="nounderline abstract_t">Procaccio F, Stocchetti N, Citerio G, et al. Guidelines for the treatment of adults with severe head trauma (part II). Criteria for medical treatment. J Neurosurg Sci 2000; 44:11.</a></li><li><a class="nounderline abstract_t">Davella D, Brambilla GL, Delfini R, et al. Guidelines for the treatment of adults with severe head trauma (part III). Criteria for surgical treatment. J Neurosurg Sci 2000; 44:19.</a></li><li><a class="nounderline abstract_t">Robinson N, Clancy M. In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature. Emerg Med J 2001; 18:453.</a></li><li><a class="nounderline abstract_t">Smith ER, Madsen JR. Neurosurgical aspects of critical care neurology. Semin Pediatr Neurol 2004; 11:169.</a></li><li><a class="nounderline abstract_t">Smith ER, Madsen JR. Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure. Semin Pediatr Neurol 2004; 11:89.</a></li><li class="breakAll">Bullock R, Clifton G. Guidelines for the Management of Severe Brain Injury, Brain Trauma Foundation/American Association of Neurologic Surgeons, New York 1995.</li><li><a class="nounderline abstract_t">Schmoker JD, Shackford SR, Wald SL, Pietropaoli JA. An analysis of the relationship between fluid and sodium administration and intracranial pressure after head injury. J Trauma 1992; 33:476.</a></li><li><a class="nounderline abstract_t">Tranmer BI, Iacobacci RI, Kindt GW. Effects of crystalloid and colloid infusions on intracranial pressure and computerized electroencephalographic data in dogs with vasogenic brain edema. Neurosurgery 1989; 25:173.</a></li><li><a class="nounderline abstract_t">SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357:874.</a></li><li><a class="nounderline abstract_t">Lassen NA, Christensen MS. Physiology of cerebral blood flow. Br J Anaesth 1976; 48:719.</a></li><li><a class="nounderline abstract_t">Rosner MJ, Coley IB. Cerebral perfusion pressure, intracranial pressure, and head elevation. J Neurosurg 1986; 65:636.</a></li><li><a class="nounderline abstract_t">Durward QJ, Amacher AL, Del Maestro RF, Sibbald WJ. Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension. J Neurosurg 1983; 59:938.</a></li><li><a class="nounderline abstract_t">Busija DW, Leffler CW, Pourcyrous M. Hyperthermia increases cerebral metabolic rate and blood flow in neonatal pigs. Am J Physiol 1988; 255:H343.</a></li><li><a class="nounderline abstract_t">Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30:142.</a></li><li><a class="nounderline abstract_t">Lassen NA. Control of cerebral circulation in health and disease. Circ Res 1974; 34:749.</a></li><li><a class="nounderline abstract_t">Gabor AJ, Brooks AG, Scobey RP, Parsons GH. Intracranial pressure during epileptic seizures. Electroencephalogr Clin Neurophysiol 1984; 57:497.</a></li><li><a class="nounderline abstract_t">Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004; 291:1350.</a></li><li><a class="nounderline abstract_t">Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002; 33:136.</a></li><li><a class="nounderline abstract_t">Munar F, Ferrer AM, de Nadal M, et al. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma 2000; 17:41.</a></li><li><a class="nounderline abstract_t">Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998; 26:1118.</a></li><li><a class="nounderline abstract_t">Shackford SR, Bourguignon PR, Wald SL, et al. Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial. J Trauma 1998; 44:50.</a></li><li><a class="nounderline abstract_t">Lescot T, Degos V, Zouaoui A, et al. Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med 2006; 34:3029.</a></li><li><a class="nounderline abstract_t">Koenig MA, Bryan M, Lewin JL 3rd, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology 2008; 70:1023.</a></li><li><a class="nounderline abstract_t">Francony G, Fauvage B, Falcon D, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008; 36:795.</a></li><li><a class="nounderline abstract_t">Ware ML, Nemani VM, Meeker M, et al. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery 2005; 57:727.</a></li><li><a class="nounderline abstract_t">Lewandowski-Belfer JJ, Patel AV, Darracott RM, et al. Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension. Neurocrit Care 2014; 20:436.</a></li><li><a class="nounderline abstract_t">Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005; 33:196.</a></li><li><a class="nounderline abstract_t">Vialet R, Albanèse J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003; 31:1683.</a></li><li><a class="nounderline abstract_t">Schwarz S, Schwab S, Bertram M, et al. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998; 29:1550.</a></li><li><a class="nounderline abstract_t">Ichai C, Armando G, Orban JC, et al. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med 2009; 35:471.</a></li><li><a class="nounderline abstract_t">Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011; 39:554.</a></li><li><a class="nounderline abstract_t">Mortazavi MM, Romeo AK, Deep A, et al. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg 2012; 116:210.</a></li><li><a class="nounderline abstract_t">Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care 2004; 10:126.</a></li><li><a class="nounderline abstract_t">Hinson HE, Stein D, Sheth KN. Hypertonic saline and mannitol therapy in critical care neurology. J Intensive Care Med 2013; 28:3.</a></li><li><a class="nounderline abstract_t">Bell BA, Smith MA, Kean DM, et al. Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone. Lancet 1987; 1:66.</a></li><li><a class="nounderline abstract_t">Millson C, James HE, Shapiro HM, Laurin R. Intracranial hypertension and brain oedema in albino rabbits. Part 2: Effects of acute therapy with diuretics. Acta Neurochir (Wien) 1981; 56:167.</a></li><li><a class="nounderline abstract_t">Nath F, Galbraith S. The effect of mannitol on cerebral white matter water content. J Neurosurg 1986; 65:41.</a></li><li><a class="nounderline abstract_t">Paczynski RP. Osmotherapy. Basic concepts and controversies. Crit Care Clin 1997; 13:105.</a></li><li><a class="nounderline abstract_t">Jafar JJ, Johns LM, Mullan SF. The effect of mannitol on cerebral blood flow. J Neurosurg 1986; 64:754.</a></li><li><a class="nounderline abstract_t">Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992; 77:584.</a></li><li><a class="nounderline abstract_t">Polderman KH, van de Kraats G, Dixon JM, et al. Increases in spinal fluid osmolarity induced by mannitol. Crit Care Med 2003; 31:584.</a></li><li><a class="nounderline abstract_t">Pollay M, Fullenwider C, Roberts PA, Stevens FA. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983; 59:945.</a></li><li><a class="nounderline abstract_t">Wilkinson HA, Rosenfeld SR. Furosemide and mannitol in the treatment of acute experimental intracranial hypertension. Neurosurgery 1983; 12:405.</a></li><li><a class="nounderline abstract_t">Chesnut RM, Marshall LF. Management of head injury. Treatment of abnormal intracranial pressure. Neurosurg Clin N Am 1991; 2:267.</a></li><li><a class="nounderline abstract_t">García-Sola R, Pulido P, Capilla P. The immediate and long-term effects of mannitol and glycerol. A comparative experimental study. Acta Neurochir (Wien) 1991; 109:114.</a></li><li><a class="nounderline abstract_t">Node Y, Nakazawa S. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon. Adv Neurol 1990; 52:359.</a></li><li><a class="nounderline abstract_t">Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004; 364:1321.</a></li><li><a class="nounderline abstract_t">Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005; 365:1957.</a></li><li class="breakAll">McLone D. Pediatric Neurosurgery: Surgery of the Developing Nervous System, 4th ed, W.B. Saunders, Philadelphia 2001. p.626.</li><li><a class="nounderline abstract_t">Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg 1991; 75:731.</a></li><li><a class="nounderline abstract_t">Hoff JT. Cerebral protection. J Neurosurg 1986; 65:579.</a></li><li><a class="nounderline abstract_t">Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med 2002; 347:43.</a></li><li><a class="nounderline abstract_t">Yundt KD, Diringer MN. The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury. Crit Care Clin 1997; 13:163.</a></li><li><a class="nounderline abstract_t">Stocchetti N, Maas AI, Chieregato A, van der Plas AA. Hyperventilation in head injury: a review. Chest 2005; 127:1812.</a></li><li><a class="nounderline abstract_t">Marion DW, Puccio A, Wisniewski SR, et al. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med 2002; 30:2619.</a></li><li><a class="nounderline abstract_t">Coles JP, Minhas PS, Fryer TD, et al. Effect of hyperventilation on cerebral blood flow in traumatic head injury: clinical relevance and monitoring correlates. Crit Care Med 2002; 30:1950.</a></li><li><a class="nounderline abstract_t">Imberti R, Bellinzona G, Langer M. Cerebral tissue PO2 and SjvO2 changes during moderate hyperventilation in patients with severe traumatic brain injury. J Neurosurg 2002; 96:97.</a></li><li><a class="nounderline abstract_t">Lafferty JJ, Keykhah MM, Shapiro HM, et al. Cerebral hypometabolism obtained with deep pentobarbital anesthesia and hypothermia (30 C). Anesthesiology 1978; 49:159.</a></li><li><a class="nounderline abstract_t">Marshall LF, Shapiro HM, Rauscher A, Kaufman NM. Pentobarbital therapy for intracranial hypertension in metabolic coma. Reye's syndrome. Crit Care Med 1978; 6:1.</a></li><li><a class="nounderline abstract_t">Messeter K, Nordström CH, Sundbärg G, et al. Cerebral hemodynamics in patients with acute severe head trauma. J Neurosurg 1986; 64:231.</a></li><li><a class="nounderline abstract_t">Nordström CH, Messeter K, Sundbärg G, et al. Cerebral blood flow, vasoreactivity, and oxygen consumption during barbiturate therapy in severe traumatic brain lesions. J Neurosurg 1988; 68:424.</a></li><li><a class="nounderline abstract_t">Marshall LF, Smith RW, Shapiro HM. The outcome with aggressive treatment in severe head injuries. Part II: acute and chronic barbiturate administration in the management of head injury. J Neurosurg 1979; 50:26.</a></li><li><a class="nounderline abstract_t">Rea GL, Rockswold GL. Barbiturate therapy in uncontrolled intracranial hypertension. Neurosurgery 1983; 12:401.</a></li><li><a class="nounderline abstract_t">Eisenberg HM, Frankowski RF, Contant CF, et al. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg 1988; 69:15.</a></li><li><a class="nounderline abstract_t">Ward JD, Becker DP, Miller JD, et al. Failure of prophylactic barbiturate coma in the treatment of severe head injury. J Neurosurg 1985; 62:383.</a></li><li><a class="nounderline abstract_t">Ng SY, Chin KJ, Kwek TK. Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series. Intensive Care Med 2011; 37:1285.</a></li><li class="breakAll">Wilkins RH, Rengachary SS. Neurosurgery, 2nd ed, McGraw-Hill, New York 1996. Vol 1, p.347.</li><li><a class="nounderline abstract_t">James HE, Langfitt TW, Kumar VS, Ghostine SY. Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir (Wien) 1977; 36:189.</a></li><li><a class="nounderline abstract_t">Marion DW, Obrist WD, Carlier PM, et al. The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report. J Neurosurg 1993; 79:354.</a></li><li><a class="nounderline abstract_t">Shiozaki T, Sugimoto H, Taneda M, et al. Effect of mild hypothermia on uncontrollable intracranial hypertension after severe head injury. J Neurosurg 1993; 79:363.</a></li><li><a class="nounderline abstract_t">Shiozaki T, Sugimoto H, Taneda M, et al. Selection of severely head injured patients for mild hypothermia therapy. J Neurosurg 1998; 89:206.</a></li><li><a class="nounderline abstract_t">Mellergård P. Changes in human intracerebral temperature in response to different methods of brain cooling. Neurosurgery 1992; 31:671.</a></li><li><a class="nounderline abstract_t">McIntyre LA, Fergusson DA, Hébert PC, et al. Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA 2003; 289:2992.</a></li><li><a class="nounderline abstract_t">Burkert W, Paver HD. [Decompressive trepanation in therapy refractory brain edema]. Zentralbl Neurochir 1988; 49:318.</a></li><li><a class="nounderline abstract_t">Burkert W, Plaumann H. [The value of large pressure-relieving trepanation in treatment of refractory brain edema. Animal experiment studies, initial clinical results]. Zentralbl Neurochir 1989; 50:106.</a></li><li><a class="nounderline abstract_t">Hatashita S, Hoff JT. The effect of craniectomy on the biomechanics of normal brain. J Neurosurg 1987; 67:573.</a></li><li><a class="nounderline abstract_t">Hatashita S, Hoff JT. Biomechanics of brain edema in acute cerebral ischemia in cats. Stroke 1988; 19:91.</a></li><li><a class="nounderline abstract_t">Rinaldi A, Mangiola A, Anile C, et al. Hemodynamic effects of decompressive craniectomy in cold induced brain oedema. Acta Neurochir Suppl (Wien) 1990; 51:394.</a></li><li><a class="nounderline abstract_t">Moody RA, Ruamsuke S, Mullan SF. An evaluation of decompression in experimental head injury. J Neurosurg 1968; 29:586.</a></li><li><a class="nounderline abstract_t">Gaab M, Knoblich OE, Fuhrmeister U, et al. Comparison of the effects of surgical decompression and resection of local edema in the therapy of experimental brain trauma. Investigation of ICP, EEG and cerebral metabolism in cats. Childs Brain 1979; 5:484.</a></li><li><a class="nounderline abstract_t">Dam Hieu P, Sizun J, Person H, Besson G. The place of decompressive surgery in the treatment of uncontrollable post-traumatic intracranial hypertension in children. Childs Nerv Syst 1996; 12:270.</a></li><li><a class="nounderline abstract_t">Gower DJ, Lee KS, McWhorter JM. Role of subtemporal decompression in severe closed head injury. Neurosurgery 1988; 23:417.</a></li><li><a class="nounderline abstract_t">Guerra WK, Gaab MR, Dietz H, et al. Surgical decompression for traumatic brain swelling: indications and results. J Neurosurg 1999; 90:187.</a></li><li><a class="nounderline abstract_t">Jourdan C, Convert J, Mottolese C, et al. [Evaluation of the clinical benefit of decompression hemicraniectomy in intracranial hypertension not controlled by medical treatment]. Neurochirurgie 1993; 39:304.</a></li><li><a class="nounderline abstract_t">Jaeger M, Soehle M, Meixensberger J. Effects of decompressive craniectomy on brain tissue oxygen in patients with intracranial hypertension. J Neurol Neurosurg Psychiatry 2003; 74:513.</a></li><li><a class="nounderline abstract_t">Carter BS, Ogilvy CS, Candia GJ, et al. One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery 1997; 40:1168.</a></li><li><a class="nounderline abstract_t">Polin RS, Shaffrey ME, Bogaev CA, et al. Decompressive bifrontal craniectomy in the treatment of severe refractory posttraumatic cerebral edema. Neurosurgery 1997; 41:84.</a></li><li><a class="nounderline abstract_t">Delashaw JB, Broaddus WC, Kassell NF, et al. Treatment of right hemispheric cerebral infarction by hemicraniectomy. Stroke 1990; 21:874.</a></li><li><a class="nounderline abstract_t">Kondziolka D, Fazl M. Functional recovery after decompressive craniectomy for cerebral infarction. Neurosurgery 1988; 23:143.</a></li><li><a class="nounderline abstract_t">Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998; 29:1888.</a></li><li><a class="nounderline abstract_t">Hofmeijer J, van der Worp HB, Kappelle LJ. Treatment of space-occupying cerebral infarction. Crit Care Med 2003; 31:617.</a></li><li><a class="nounderline abstract_t">Pranesh MB, Dinesh Nayak S, Mathew V, et al. Hemicraniectomy for large middle cerebral artery territory infarction: outcome in 19 patients. J Neurol Neurosurg Psychiatry 2003; 74:800.</a></li><li><a class="nounderline abstract_t">Albanèse J, Leone M, Alliez JR, et al. Decompressive craniectomy for severe traumatic brain injury: Evaluation of the effects at one year. Crit Care Med 2003; 31:2535.</a></li><li><a class="nounderline abstract_t">Diedler J, Sykora M, Blatow M, et al. Decompressive surgery for severe brain edema. J Intensive Care Med 2009; 24:168.</a></li><li><a class="nounderline abstract_t">Fields JD, Lansberg MG, Skirboll SL, et al. "Paradoxical" transtentorial herniation due to CSF drainage in the presence of a hemicraniectomy. Neurology 2006; 67:1513.</a></li><li><a class="nounderline abstract_t">Oyelese AA, Steinberg GK, Huhn SL, Wijman CA. Paradoxical cerebral herniation secondary to lumbar puncture after decompressive craniectomy for a large space-occupying hemispheric stroke: case report. Neurosurgery 2005; 57:E594; discussion E594.</a></li><li><a class="nounderline abstract_t">Sarov M, Guichard JP, Chibarro S, et al. Sinking skin flap syndrome and paradoxical herniation after hemicraniectomy for malignant hemispheric infarction. Stroke 2010; 41:560.</a></li></ol></div><div id="topicVersionRevision">Topic 1659 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Adams RA, Ropper AH. Principles of neurology, 6th ed, McGraw Hill, New York 1997.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7373397" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The intracranial pressure in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7373397" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The intracranial pressure in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7373397" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The intracranial pressure in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : An account of the appearence observed in the dissection of two of the individuals presumed to have perished in the storm of the third, and whose bodies were discovered in the vicinity of Leith on the morning of the 24th, November 1821; with some reflections on the pathology of the brain</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : An account of the appearence observed in the dissection of two of the individuals presumed to have perished in the storm of the third, and whose bodies were discovered in the vicinity of Leith on the morning of the 24th, November 1821; with some reflections on the pathology of the brain</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7452330" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Diffuse cerebral swelling following head injuries in children: the syndrome of "malignant brain edema".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1738026" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Diffuse brain swelling in severely head-injured children. A report from the NIH Traumatic Coma Data Bank.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1407426" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Severe head injury in children: experience of the Traumatic Coma Data Bank.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1407426" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Severe head injury in children: experience of the Traumatic Coma Data Bank.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2757806" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Cerebral blood flow and its pathophysiology in hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6516910" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Visual disturbances and occipital brain infarct following acute, transient hypotension in hypertensive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/641549" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Autoregulation and CO2 responses of cerebral blood flow in patients with acute severe head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4640619" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The upper limit of autoregulation of cerebral blood flow--on the pathogenesis of hypertensive encepholopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7968030" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Management of hypertensive emergencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15258230" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Raised intracranial pressure presenting with spontaneous periorbital bruising: two case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15258230" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Raised intracranial pressure presenting with spontaneous periorbital bruising: two case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Incisura of the crus due to contralateral brain tumor</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15046669" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Transcranial motor evoked potential recording in a case of Kernohan's notch syndrome: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7490638" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cerebral perfusion pressure: management protocol and clinical results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11129833" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Intracranial pressure monitoring and outcomes after traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12163808" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Management of severe head injury: institutional variations in care and effect on outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18365169" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Monitoring of intracranial pressure in patients with severe traumatic brain injury: an Austrian prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12171853" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Management of head trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12171853" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Management of head trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11889475" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Diagnosis and management of increased intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2213158" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8271021" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Role of intracranial pressure monitoring in severely head-injured patients without signs of intracranial hypertension on initial computerized tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3772476" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Normal computerized tomography scans in severe head injury. Prognostic and clinical management implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17511545" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure monitoring technology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6694707" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Ventriculostomy-related infections. A prospective epidemiologic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8751626" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7496747" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Intracranial pressure monitoring techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3598682" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Continuous monitoring of intracranial pressure with a miniaturized fiberoptic device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1436417" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Monitoring of brain tissue pressure with a fiberoptic device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8923072" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Bedside burr hole for intracranial pressure monitoring performed by intensive care physicians. A 5-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11990350" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Fiberoptic intraparenchymal brain pressure monitoring with the Camino V420 monitor: reflections on our experience in 163 severely head-injured patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11846910" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The Camino intracranial pressure sensor: is it optimal technology? An internal audit with a review of current intracranial pressure monitoring technologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3748354" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Inaccurate pressure readings for subarachnoid bolts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8093756" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Complications of intracranial pressure monitoring in fulminant hepatic failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1782538" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Plateau-wave phenomenon (I). Correlation between the appearance of plateau waves and CSF circulation in patients with intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6693959" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Origin and evolution of plateau waves. Experimental observations and a theoretical model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9012577" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Transcranial Doppler ultrasonography in the neurocritical care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15591334" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Non-invasive assessment of cerebral perfusion pressure in brain injured patients with moderate intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3282040" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Transcranial Doppler ultrasonography in raised intracranial pressure and in intracranial circulatory arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7143059" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11835721" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Outcome prediction in severe traumatic brain injury with transcranial Doppler ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23715045" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Measuring elevated intracranial pressure through noninvasive methods: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12066918" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Tissue resonance analysis; a novel method for noninvasive monitoring of intracranial pressure. Technical note.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18477382" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Optic nerve sonography in the diagnostic evaluation of adult brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19636971" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Reliability of optic nerve ultrasound for the evaluation of patients with spontaneous intracranial hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19098619" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Optic nerve ultrasound for detection of intracranial hypertension in intracranial hemorrhage patients: confirmation of previous findings in a different patient population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21505900" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17668184" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Ultrasonography of the optic nerve sheath may be useful for detecting raised intracranial pressure after severe brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18509619" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Non-invasive assessment of intracranial pressure using ocular sonography in neurocritical care patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18275454" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15111918" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The relationship of intraocular pressure to intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10752710" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Intraocular pressure changes and alterations in intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18570302" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : No correlation between intraocular pressure and intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21710618" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Measurement of intraocular and intracranial pressure: is there a relationship?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4045519" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : A new method for noninvasive measurement of short-term cerebrospinal fluid pressure changes in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2732731" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Mean intracranial pressure monitoring by a non-invasive audiological technique: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10961490" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Guidelines for the treatment of adults with severe head trauma (part I). Initial assessment; evaluation and pre-hospital treatment; current criteria for hospital admission; systemic and cerebral monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10961491" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Guidelines for the treatment of adults with severe head trauma (part II). Criteria for medical treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10961492" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Guidelines for the treatment of adults with severe head trauma (part III). Criteria for surgical treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11696494" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15259869" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Neurosurgical aspects of critical care neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15259863" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15259863" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1404521" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : An analysis of the relationship between fluid and sodium administration and intracranial pressure after head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2671780" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Effects of crystalloid and colloid infusions on intracranial pressure and computerized electroencephalographic data in dogs with vasogenic brain edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17761591" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Saline or albumin for fluid resuscitation in patients with traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7284" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Physiology of cerebral blood flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3772451" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Cerebral perfusion pressure, intracranial pressure, and head elevation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6631516" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3136668" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Hyperthermia increases cerebral metabolic rate and blood flow in neonatal pigs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11902255" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4598993" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Control of cerebral circulation in health and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6202480" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Intracranial pressure during epileptic seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15026402" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11779902" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10674757" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9635664" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Treatment of refractory intracranial hypertension with 23.4% saline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9464749" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16971850" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18272864" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Reversal of transtentorial herniation with hypertonic saline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18209674" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16239885" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24026522" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15644669" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12794404" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9707191" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18807008" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21242790" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21942722" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15075723" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Hypertonic saline solutions in brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21436162" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Hypertonic saline and mannitol therapy in critical care neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2879175" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6791466" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Intracranial hypertension and brain oedema in albino rabbits. Part 2: Effects of acute therapy with diuretics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3086519" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : The effect of mannitol on cerebral white matter water content.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9012578" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Osmotherapy. Basic concepts and controversies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3084719" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : The effect of mannitol on cerebral blood flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1527619" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Aggravation of vasogenic cerebral edema by multiple-dose mannitol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12576970" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Increases in spinal fluid osmolarity induced by mannitol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6415245" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6406929" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Furosemide and mannitol in the treatment of acute experimental intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1821741" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Management of head injury. Treatment of abnormal intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1907077" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : The immediate and long-term effects of mannitol and glycerol. A comparative experimental study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2118716" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15474134" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15936423" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15936423" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1919695" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3534160" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Cerebral protection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12097540" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Hypocapnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9012580" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15888864" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Hyperventilation in head injury: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12483048" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12352026" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Effect of hyperventilation on cerebral blood flow in traumatic head injury: clinical relevance and monitoring correlates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11794610" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Cerebral tissue PO2 and SjvO2 changes during moderate hyperventilation in patients with severe traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/686436" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Cerebral hypometabolism obtained with deep pentobarbital anesthesia and hypothermia (30 C).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/639524" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Pentobarbital therapy for intracranial hypertension in metabolic coma. Reye's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3080555" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Cerebral hemodynamics in patients with acute severe head trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3125310" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Cerebral blood flow, vasoreactivity, and oxygen consumption during barbiturate therapy in severe traumatic brain lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/758375" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : The outcome with aggressive treatment in severe head injuries. Part II: acute and chronic barbiturate administration in the management of head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6856064" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Barbiturate therapy in uncontrolled intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3288723" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3882899" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Failure of prophylactic barbiturate coma in the treatment of severe head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21567112" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21567112" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/848367" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8360731" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8360732" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Effect of mild hypothermia on uncontrollable intracranial hypertension after severe head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9688114" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Selection of severely head injured patients for mild hypothermia therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1407452" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Changes in human intracerebral temperature in response to different methods of brain cooling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12799408" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3075392" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : [Decompressive trepanation in therapy refractory brain edema].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2624017" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : [The value of large pressure-relieving trepanation in treatment of refractory brain edema. Animal experiment studies, initial clinical results].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3655895" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : The effect of craniectomy on the biomechanics of normal brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3336907" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Biomechanics of brain edema in acute cerebral ischemia in cats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2089950" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Hemodynamic effects of decompressive craniectomy in cold induced brain oedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5708031" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : An evaluation of decompression in experimental head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/477464" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Comparison of the effects of surgical decompression and resection of local edema in the therapy of experimental brain trauma. Investigation of ICP, EEG and cerebral metabolism in cats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8737804" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : The place of decompressive surgery in the treatment of uncontrollable post-traumatic intracranial hypertension in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3200370" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Role of subtemporal decompression in severe closed head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9950487" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Surgical decompression for traumatic brain swelling: indications and results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8065488" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : [Evaluation of the clinical benefit of decompression hemicraniectomy in intracranial hypertension not controlled by medical treatment].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12640077" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Effects of decompressive craniectomy on brain tissue oxygen in patients with intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9179889" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : One-year outcome after decompressive surgery for massive nondominant hemispheric infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9218299" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Decompressive bifrontal craniectomy in the treatment of severe refractory posttraumatic cerebral edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2349590" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Treatment of right hemispheric cerebral infarction by hemicraniectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3185872" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Functional recovery after decompressive craniectomy for cerebral infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9731614" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Early hemicraniectomy in patients with complete middle cerebral artery infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12576974" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Treatment of space-occupying cerebral infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12754357" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Hemicraniectomy for large middle cerebral artery territory infarction: outcome in 19 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14530763" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Decompressive craniectomy for severe traumatic brain injury: Evaluation of the effects at one year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19321537" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Decompressive surgery for severe brain edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17060591" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : "Paradoxical" transtentorial herniation due to CSF drainage in the presence of a hemicraniectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16145506" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Paradoxical cerebral herniation secondary to lumbar puncture after decompressive craniectomy for a large space-occupying hemispheric stroke: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20056926" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Sinking skin flap syndrome and paradoxical herniation after hemicraniectomy for malignant hemispheric infarction.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
